From a thorough history going back decades to a mass meeting of experts, identifying occupational lung diseases can be ...

001) correlated to three lung function measures ... as well as a variety of background and individual factors such as the type of wood and a patient’s comorbidities. Next steps should be ...

Dupilumab improved exacerbations and lung function in patients with COPD and T2 inflammation, regardless of baseline BODE index score.

Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...

A new study provides the latest results on a breath test for detecting silicosis powered by artificial intelligence (AI).

Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

Blagosklonny goes on to write that even though rapamycin may reverse some manifestations of aging, it is more effective at ...

Nephrogenic systemic fibrosis can cause a thickening and hardening of the skin, heart and lungs—and cause painful contracting of the joints.

Regeneron (REGN) and Sanofi (SNY) announced that the Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing ...